The risk of acute disseminated encephalomyelitis (ADEM) following covid-19 vaccination in England: A self-controlled case-series analysis
Acute disseminated encephalomyelitis (ADEM) has been identified as an Adverse Event of Special Interest in the COVID-19 vaccine programme due to its long-standing temporal association with a wide range of other vaccines. Case reports of ADEM shortly following COVID−19 vaccination have now been docum...
Saved in:
| Main Authors: | Julia Stowe, Jamie Lopez-Bernal, Nick Andrews |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2311969 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acute Disseminated Encephalomyelitis Following Completion of Pneumococcal Meningitis Treatment: A Case Report and Review of the Literature
by: Ayşe Serra ÖZEL, et al.
Published: (2023-05-01) -
Reversible sensorineural hearing loss in a late presentation of acute disseminated encephalomyelitis: A case report
by: Laith Haddad, et al.
Published: (2025-12-01) -
CLINICAL СASE OF INFLUENZA A(H1N1) COMPLICATED WITH ACUTE DISSEMINATED ENCEPHALOMYELITIS
by: L. N. Mazankova, et al.
Published: (2018-09-01) -
Comparative characteristic of laboratory indicators for encephalitis, disseminated encephalomyelitis and multiple sclerosis in children
by: E. Y. Skripchenko, et al.
Published: (2018-11-01) -
Clinical polymorphism of acute disseminated encephalomyelitis: diagnosis, treatment, long-term prognosis. Lecture with the description of clinical cases
by: V. E. Avdeeva, et al.
Published: (2023-06-01)